Researchers from the Queensland Brain Institute have secured more than $3.2million in National Health and Medical Research Council Ideas Grants.
The funding was awarded to four projects across the institute to support a range of basic science and clinical research.
Recipients include Professor Darryl Eyles for research into the intranasal delivery of the antipsychotic drug, clozapine, to reduce side effects in schizophrenia patients.
Dr Liviu Bodea will research microglia’s response to amyloid-B to determine if it can be targeted to reduce Alzheimer’s disease.
Associate Professor Victor Anggono will investigate the normal role of the protein tau in the brain to better understand how it goes wrong in disease.
Professor Peter Nestor will use ultra-high-field MRI to investigate brain iron abnormalities in neurodegenerative diseases to find a cure or prevention for acute conditions including Parkinson’s disease and essential tremor.
